查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018755

PTA球囊導管市場：2026-2032年全球市場預測（依產品類型、球囊材料、應用、最終用戶和銷售管道分類）

PTA Balloon Catheter Market by Product Type, Balloon Material, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

PTA球囊導管市場預計到2025年將達到32.3億美元，到2026年將成長到34.7億美元，到2032年將達到52.3億美元，複合年成長率為7.09%。

主要市場統計數據
基準年 2025 32.3億美元
預計年份：2026年 34.7億美元
預測年份 2032 52.3億美元
複合年成長率 (%) 7.09%

對經皮血管成形術 (PTA) 球囊技術、臨床應用案例以及影響採用和採購決策的相關人員決策因素進行全面概述。

本篇摘要將說明現代經皮經皮血管成形術（PTA）球囊導管的臨床應用、器械發展演變以及相關人員趨勢。從臨床需求出發，PTA 仍然是恢復冠狀動脈、神經血管和周邊血管解剖結構通暢性性的基石治療方法，而器械的創新不斷改變手術成功與長期血管健康之間的平衡。同時，臨床醫師和採購團隊在選擇器械時，不僅考慮其即時輸送和擴張特性，還會考慮藥物塗層和精準切割技術帶來的長期治療效果。

臨床證據、材料技術的進步和不斷發展的醫療保健服務模式的整合如何從根本上改變 PTA 球囊的設備選擇、採購和臨床路徑。

經皮腔內血管成形術（PTA）球囊導管領域正經歷著一場變革，這主要得益於臨床證據的積累、材料科學的進步以及治療輸送模式的改變，所有這些因素共同作用，旨在改善手術效果。在臨床方面，真實世界數據（REW）的累積和影像技術的進步提高了病變評估和器械選擇的準確性，使臨床醫生能夠根據病變形態選擇合適的球囊類型，而不再僅僅依賴傳統方案。同時，高性能尼龍、聚對苯二甲酸乙二醇酯（PET）結構和先進聚氨酯等材料的創新拓展了可實現的充氣壓力和外形最佳化範圍，從而在順應性和徑向強度之間形成了新的權衡。

評估累積關稅調整和貿易政策變化如何推動球囊導管製造業的結構重組、在地化和韌性策略。

關稅環境和國際貿易措施是醫療設備全球供應鏈規劃的關鍵因素，而近期政策調整進一步加劇了球囊導管組件和成品採購決策的複雜性。關稅波動會影響各製造區域的相對競爭力，影響垂直整合生產和外部採購組件的選擇，並改變區域進口成本。這些趨勢迫使製造商重新評估其多供應商策略，並提高對關鍵原料（例如特殊聚合物和塗料化學品）的層級供應商關係的透明度。

將產品分類、解剖應用、最終用戶環境、材料選擇和分銷管道與策略商業性定位聯繫起來的多方面細分洞察。

深入的細分分析揭示了產品、應用、終端用戶、材料和銷售管道這五個維度如何共同決定球囊導管相關人員的商業性和臨床策略。從產品角度來看，傳統球囊、切割球囊和藥物塗層球囊分別滿足不同的手術需求。在傳統球囊中，順應性、非順應性和半相容這三種分類會影響臨床醫師基於病變順應性和所需血管支架的偏好。另一方面，藥物塗層球囊的臨床定位則取決於所使用的藥物是紫杉醇還是Sirolimus，以及塗層在充氣過程中的釋放方式。

清晰的區域洞察，區分美洲、歐洲、中東和非洲市場以及亞太地區的商業性方法，最佳化部署、兌換和供應策略。

區域趨勢正在形成多樣化的需求模式和監管環境，這對商業化和臨床導入策略產生重大影響。在美洲，先進的心臟導管介入基礎設施和廣泛的三級醫療中心覆蓋推動了手術量的成長和分階段器械創新技術的早期應用，同時，報銷框架和區域供應鏈能力也影響著採購行為。歐洲、中東和非洲（EMEA）地區則呈現顯著的異質性。雖然西歐市場通常強調循證應用和嚴格的採購競標，全部區域EMEA新興市場則優先考慮成本效益和可擴展的庫存模式，從而導致了不同的市場進入策略。

創新驅動型公司如何平衡研發、臨床證據的創造和生產柔軟性，以確保競爭優勢和持續的臨床應用？

PTA球囊導管領域的主要企業正致力於結合針對性的研發投資、策略夥伴關係和靈活的生產製造能力，以保持差異化優勢。許多企業正在將資源重新分配到材料科學和塗層技術方面，以改善導管的輸送性能和生物相容性；而另一些企業則優先透過研究者主導的臨床研究和參與註冊登記來積累臨床證據，從而支持其關於導管耐用性和安全性的聲明。與醫院系統和關鍵意見領袖（KOL）的合作仍然是檢驗導管在複雜解剖結構中的性能以及產生真實世界數據（REW）的核心策略，以支援導管在急診和門診環境中的應用。

為醫療設備製造商提供切實有效的建議，使其產品策略、證據產生和供應鏈韌性與其獨特的臨床和商業性現實相適應。

產業領導者應採取一系列切實可行的舉措，以增強自身競爭優勢並加速臨床應用。首先，他們應將產品開發藍圖與特定治療領域相匹配，透過結合不同的材料和塗層方案來應對特定的病變類型，從而減少器械選擇的臨床不確定性。其次，他們應投資於切實可行的臨床證據項目，利用註冊研究和真實世界數據來補充隨機試驗，以證明產品在不同患者群體和醫療環境中的價值。第三，他們應採取地域均衡的供應策略，將區域性生產與關鍵材料的多通路採購結合，以降低關稅和物流風險，同時維持品管。

高度透明的混合方法研究設計，結合了第二手資料的整合和專家的一手檢驗，確保了研究結果的嚴謹性和可重複性，以及明確的局限性。

本研究採用綜合調查方法，結合結構化的二手資料和一手質性檢驗，建構了穩健且可重複的證據基礎。二手資料分析整合了同行評審的臨床文獻、監管申報文件、材料科學出版物和操作指南，對醫療設備的分類、應用案例和已知的安全注意事項進行了梳理。在此基礎上，一手研究對介入醫師、採購負責人和醫療設備研發經理進行了半結構式訪談，以檢驗市場動態，深入探究推廣應用的障礙，並揭示不同醫療機構間細微的操作差異。

這一結論將醫療設備創新、臨床策略和營運韌性聯繫起來，並將它們整合為可操作的挑戰，以實現永續的臨床部署和商業性成功。

總之，PTA球囊導管領域正處於一個轉折點，臨床細微差別、材料創新和供應鏈策略在此交匯融合，為器械製造商、臨床醫生和支付方創造了差異化的機會。醫療設備的選擇越來越注重病灶特異性和實證醫學，迫使企業調整產品設計以適應明確的應用場景，同時維持強而有力的上市後監測。貿易政策的波動和關稅調整進一步增加了營運的複雜性，促使企業更加重視在地化生產和靈活的籌資策略。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：PTA球囊導管市場：依產品類型分類

  • 傳統球囊
    • 合規
    • 不合規
    • 半相容
  • 切割球囊
  • 藥物塗層氣球
    • 紫杉醇塗層
    • Sirolimus塗層

第9章：PTA球囊導管市場（依球囊材質分類）

  • 尼龍
  • PET
  • 聚氨酯

第10章：PTA球囊導管市場：依應用領域分類

  • 冠狀動脈成形術
    • 分支
    • 原冠狀動脈
  • 神經血管成形術
    • 顱外
    • 顱內
  • 周邊血管成形術
    • 股膕窩
    • 髂骨
    • 腎

第11章 PTA球囊導管市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第12章：PTA球囊導管市場：依銷售管道分類

  • 離線
  • 線上

第13章：PTA球囊導管市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 PTA球囊導管市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：PTA球囊導管市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國PTA球囊導管市場

第17章：中國PTA球囊導管市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Accura Medizintechnik GmbH
  • Andratec GmbH
  • AV Medical Technologies Ltd.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • BrosMed Medical Co., Ltd
  • Cardinal Health, Inc.
  • Conic Vascular
  • Cook Medical Inc.
  • Freudenberg & Co. KG
  • Infinity Angioplasty Balloon Company
  • Koninklijke Philips NV
  • Leo Medical Co.,Ltd.
  • Medcaptain Medical Technology Co., Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Nordson Corporation
  • NuMED
  • Poba Medical
  • Q3 Medical Devices Limited
  • QX Medical LLC
  • Ridgeback Technologies
  • Simeks Medical
  • Teleflex Incorporated
  • Terumo Medical Corporation
Product Code: MRR-A26E0E5741FA

The PTA Balloon Catheter Market was valued at USD 3.23 billion in 2025 and is projected to grow to USD 3.47 billion in 2026, with a CAGR of 7.09%, reaching USD 5.23 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.23 billion
Estimated Year [2026] USD 3.47 billion
Forecast Year [2032] USD 5.23 billion
CAGR (%) 7.09%

Comprehensive orientation to percutaneous transluminal angioplasty balloon technology, clinical use cases, and stakeholder decision drivers shaping adoption and procurement choices

This executive introduction orients readers to the clinical application, device evolution, and stakeholder dynamics that define the contemporary PTA balloon catheter environment. Beginning with the clinical imperative, percutaneous transluminal angioplasty remains a cornerstone intervention for restoring vessel patency across coronary, neurovascular, and peripheral anatomies, and device innovations have continuously shifted the balance between procedural success and long-term vessel health. In parallel, clinicians and procurement teams now weigh device selection not only on immediate deliverability and inflation characteristics but also on long-term outcomes influenced by pharmacologic coatings and precision cutting technologies.

Moving from practice patterns to product taxonomy, the market encompasses conventional balloons, cutting balloons, and drug coated balloons, each with material and compliance attributes that materially affect clinical handling. Conventional balloons are evaluated across compliant, non-compliant, and semi-compliant performance envelopes, while drug coated variants differ by antiproliferative agents such as paclitaxel and sirolimus. These technical distinctions intersect with setting of care choices, ranging from ambulatory surgical centers to high-acuity hospitals, and with procurement channels that now include both offline and online sales pathways. Taken together, the introduction frames a multi-stakeholder landscape where clinical evidence, device engineering, and distribution strategy interact to shape adoption dynamics.

How converging clinical evidence, material advances, and evolving care delivery models are fundamentally reshaping device selection, procurement, and clinical pathways for PTA balloons

The PTA balloon catheter landscape is undergoing transformative shifts driven by converging clinical evidence, material science advances, and changes in delivery models that collectively elevate procedural outcomes. On the clinical front, growing real-world evidence and refined imaging modalities have increased the precision of lesion assessment and device selection, prompting clinicians to choose balloon types aligned to lesion morphology rather than defaulting to legacy options. Meanwhile, material innovations such as high-performance nylons, polyethylene terephthalate constructs, and advanced polyurethanes have expanded the envelope of achievable inflation pressures and profile optimization, thereby enabling new trade-offs between trackability and radial strength.

Concurrently, drug coated technologies are being reevaluated with more granular attention to drug formulation, excipient systems, and coating transfer efficiency, fostering a move towards agent-specific clinical strategies. Distribution and procurement are also shifting, with online channels complementing traditional offline pathways and ambulatory settings gaining relevance for selected low-complexity procedures. Regulatory expectations and payer scrutiny have further incentivized manufacturers to align product development with clear endpoints and robust post-market evidence generation. As a result, industry actors who integrate clinical insight, material differentiation, and distribution agility are best positioned to capture the next wave of procedural demand.

Assessment of how cumulative tariff adjustments and trade policy changes are prompting structural supply chain reconfiguration, localization, and resilience strategies across balloon catheter manufacturing

Tariff environments and international trade measures have become material factors in planning global supply chains for medical devices, and recent policy adjustments have added complexity to sourcing decisions for balloon catheter components and finished products. Tariff shifts impact the relative competitiveness of manufacturing geographies, influence choices between vertically integrated production versus outsourced components, and alter landed costs across regions. Those dynamics compel manufacturers to reassess multi-sourcing strategies and to seek greater visibility into tiered supplier relationships for key inputs such as specialized polymers and coating chemistries.

In response, companies are accelerating localization efforts where feasible, optimizing inventory strategies, and renegotiating contractual frameworks to insulate against further trade policy volatility. Regulatory harmonization efforts and bilateral trade agreements can mitigate some cost pressures, but procurement teams increasingly adopt scenario planning to quantify exposure and to prioritize supply resilience over narrow cost optimization. For organizations that serve diverse regional markets, the cumulative effect of tariff changes has driven a more deliberate approach to production footprint, quality oversight, and logistics partnerships to ensure continuity of supply without compromising clinical standards.

Multi-dimensional segmentation insights linking product classes, anatomical applications, end-user settings, material choices, and distribution channels to strategic commercial positioning

Insightful segmentation analysis reveals how product, application, end user, material, and sales channel dimensions jointly define commercial and clinical strategies for balloon catheter stakeholders. From a product perspective, conventional balloons, cutting balloons, and drug coated balloons each address distinct procedural needs; within conventional devices, the compliant, non-compliant, and semi-compliant classifications drive clinician preference based on lesion compliance and required vessel scaffolding, whereas drug coated balloons diverge in clinical positioning depending on whether paclitaxel or sirolimus is used and how the coating is delivered during inflation.

Application-based distinctions further refine strategy, as coronary angioplasty procedures-encompassing both bifurcation and native coronary indications-demand different deliverability and recoil characteristics compared with neurovascular angioplasty procedures that involve extracranial or intracranial anatomy with heightened tortuosity and safety considerations. Peripheral interventions such as femoropopliteal, iliac, and renal procedures emphasize durable lesion patency and may favor drug coated approaches in specific lesion contexts. End-user segmentation across ambulatory surgical centers, clinics, and hospitals affects purchasing cycles, inventory holding patterns, and training requirements. Balloon materials-nylon, PET, and polyurethane-bring trade-offs in compliance and burst strength, while sales channels split between offline and online avenues, each with implications for customer engagement, post-sale support, and regulatory documentation. Synthesizing these dimensions supports tailored value propositions that align device attributes to clinical needs and procurement realities.

Clear-eyed regional insights that differentiate commercial approaches across the Americas, EMEA markets, and Asia-Pacific to optimize adoption, reimbursement, and supply strategies

Regional dynamics create heterogeneous demand patterns and regulatory landscapes that materially influence commercialization and clinical adoption strategies. In the Americas, advanced interventional cardiology infrastructure and broad access to tertiary care centers drive high procedural volumes and early adoption of incremental device innovations, while reimbursement frameworks and regional supply chain capabilities also shape purchasing behavior. Europe, the Middle East, and Africa exhibit considerable heterogeneity; western European markets often emphasize evidence-based adoption and rigorous procurement tenders, whereas emerging markets across the broader EMEA region prioritize cost-efficiency and scalable inventory models, resulting in differentiated go-to-market approaches.

Asia-Pacific markets present a mix of rapid clinical modernization, localized manufacturing capacity, and diverse regulatory pathways, prompting many companies to calibrate market entry strategies by country. Transitional phrases are important here because cross-border regulatory harmonization and regional manufacturing investments can change competitive dynamics quickly; companies with adaptive regulatory teams and regional commercial partners can accelerate uptake by aligning clinical evidence generation and pricing strategies to local practice patterns. Ultimately, tailoring product portfolios and engagement models to the specific needs of each region enhances both adoption and long-term clinical integration.

How innovation-focused firms are balancing R&D, clinical evidence generation, and manufacturing flexibility to secure competitive advantage and consistent clinical adoption

Leading companies in the PTA balloon catheter space are emphasizing a combination of targeted R&D investments, strategic partnerships, and manufacturing agility to sustain differentiation. Many firms are reallocating resources toward materials science and coating technologies to improve deliverability and biological interaction, while others prioritize cultivating clinical evidence through investigator-initiated studies and registry participation to substantiate claims around durability and safety. Collaboration with hospital systems and key opinion leaders remains a central tactic to validate device performance in complex anatomies and to create real-world evidence that supports adoption in both high-acuity and ambulatory settings.

At the same time, commercial strategies increasingly integrate digital tools for customer engagement, inventory analytics, and procedural training to reduce friction in purchasing and to enhance post-sale support. Several players are also pursuing manufacturing footprint optimization, either through strategic contracts with regional manufacturing partners or through selective vertical integration, to reduce lead times and improve quality control. Those that balance innovation with disciplined regulatory execution and pragmatic supply chain planning are better positioned to navigate payer scrutiny and to sustain adoption across diverse clinical and geographic contexts.

Practical, high-impact recommendations for device makers to align product strategy, evidence generation, and supply chain resilience with distinct clinical and commercial realities

Industry leaders should pursue a set of actionable initiatives to strengthen competitive positioning and to accelerate clinical uptake. First, align product development roadmaps with specific procedural niches by combining material and coating choices to address distinct lesion sets, thereby reducing clinical ambiguity in device selection. Second, invest in pragmatic clinical evidence programs that complement randomized trials with registries and real-world data to demonstrate value for diverse patient populations and care settings. Third, adopt a geographically nuanced supply strategy that blends regional manufacturing with multi-sourcing for critical inputs to mitigate tariff and logistics risk while maintaining quality oversight.

Furthermore, optimize commercial models by tailoring sales and education approaches to ambulatory surgical centers, clinics, and hospitals, recognizing that each end-user cohort has unique purchasing cycles and training needs. Enhance digital engagement and e-commerce readiness to support online sales channels while preserving the high-touch relationships that drive complex device adoption. Finally, seek strategic partnerships for coating technology, distribution, or post-market surveillance to accelerate time-to-clinic and to share development risk, ensuring that each initiative has clear metrics and accountable owners to track progress and impact.

Transparent mixed-methods research design combining secondary synthesis and primary expert validation to ensure rigorous, reproducible insights and clear limitations

This research applied an integrated methodology that combined structured secondary intelligence with primary qualitative validation to create a robust, reproducible evidence base. Secondary analysis synthesized peer-reviewed clinical literature, regulatory filings, material science publications, and procedural guidelines to map device classes, use cases, and known safety considerations. Building on that foundation, primary research included semi-structured interviews with interventional clinicians, procurement professionals, and device development leaders to validate market dynamics, to probe adoption barriers, and to surface operational nuances across different care settings.

Data triangulation procedures reconciled findings across sources and ensured consistency between clinical insights and commercial realities. Segmentation logic was applied to align product, application, end-user, material, and sales channel dimensions, and regional analysis considered regulatory pathways and supply chain configurations. Limitations included variability in publicly available proprietary data and the evolving nature of post-market evidence, factors that were mitigated by prioritizing contemporary primary interviews and cross-validation with multiple expert respondents. The methodological approach emphasizes transparency, traceability, and adaptability to future updates.

Concluding synthesis linking device innovation, clinical strategy, and operational resilience to actionable imperatives for sustained clinical adoption and commercial success

In conclusion, the PTA balloon catheter domain is at an inflection point where clinical nuance, material innovation, and supply chain strategy intersect to create differentiated opportunities for device manufacturers, clinicians, and payers. Device selection is becoming more lesion-specific and evidence-driven, prompting companies to match product engineering with clear clinical use cases while sustaining robust post-market surveillance. Trade policy volatility and tariff adjustments add an additional layer of operational complexity, encouraging greater emphasis on localized manufacturing and resilient sourcing strategies.

Ultimately, organizations that integrate targeted R&D, pragmatic evidence generation, and flexible commercial models will be best positioned to translate technological advances into sustained clinical adoption. The interplay between product design, clinical application, end-user environment, material choice, and distribution channel underscores the importance of a holistic strategy that anticipates regulatory, reimbursement, and supply chain contingencies while delivering demonstrable clinical value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. PTA Balloon Catheter Market, by Product Type

  • 8.1. Conventional Balloon
    • 8.1.1. Compliant
    • 8.1.2. Non-Compliant
    • 8.1.3. Semi-Compliant
  • 8.2. Cutting Balloon
  • 8.3. Drug Coated Balloon
    • 8.3.1. Paclitaxel Coated
    • 8.3.2. Sirolimus Coated

9. PTA Balloon Catheter Market, by Balloon Material

  • 9.1. Nylon
  • 9.2. PET
  • 9.3. Polyurethane

10. PTA Balloon Catheter Market, by Application

  • 10.1. Coronary Angioplasty
    • 10.1.1. Bifurcation
    • 10.1.2. Native Coronary
  • 10.2. Neurovascular Angioplasty
    • 10.2.1. Extracranial
    • 10.2.2. Intracranial
  • 10.3. Peripheral Angioplasty
    • 10.3.1. Femoropopliteal
    • 10.3.2. Iliac
    • 10.3.3. Renal

11. PTA Balloon Catheter Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. PTA Balloon Catheter Market, by Sales Channel

  • 12.1. Offline
  • 12.2. Online

13. PTA Balloon Catheter Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. PTA Balloon Catheter Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. PTA Balloon Catheter Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States PTA Balloon Catheter Market

17. China PTA Balloon Catheter Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Accura Medizintechnik GmbH
  • 18.7. Andratec GmbH
  • 18.8. AV Medical Technologies Ltd.
  • 18.9. B. Braun SE
  • 18.10. Becton, Dickinson and Company
  • 18.11. Biosensors International Group, Ltd.
  • 18.12. BIOTRONIK SE & Co. KG
  • 18.13. Boston Scientific Corporation
  • 18.14. BrosMed Medical Co., Ltd
  • 18.15. Cardinal Health, Inc.
  • 18.16. Conic Vascular
  • 18.17. Cook Medical Inc.
  • 18.18. Freudenberg & Co. KG
  • 18.19. Infinity Angioplasty Balloon Company
  • 18.20. Koninklijke Philips N.V.
  • 18.21. Leo Medical Co.,Ltd.
  • 18.22. Medcaptain Medical Technology Co., Ltd.
  • 18.23. Medtronic PLC
  • 18.24. Meril Life Sciences Pvt. Ltd.
  • 18.25. MicroPort Scientific Corporation
  • 18.26. Nordson Corporation
  • 18.27. NuMED
  • 18.28. Poba Medical
  • 18.29. Q3 Medical Devices Limited
  • 18.30. QX Medical LLC
  • 18.31. Ridgeback Technologies
  • 18.32. Simeks Medical
  • 18.33. Teleflex Incorporated
  • 18.34. Terumo Medical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PTA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PTA BALLOON CATHETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PTA BALLOON CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PTA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PTA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY COMPLIANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY COMPLIANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY COMPLIANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NON-COMPLIANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NON-COMPLIANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NON-COMPLIANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SEMI-COMPLIANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SEMI-COMPLIANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SEMI-COMPLIANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CUTTING BALLOON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CUTTING BALLOON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CUTTING BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PACLITAXEL COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PACLITAXEL COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PACLITAXEL COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SIROLIMUS COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SIROLIMUS COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SIROLIMUS COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY BIFURCATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY BIFURCATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY BIFURCATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NATIVE CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NATIVE CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NATIVE CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY EXTRACRANIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY EXTRACRANIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY EXTRACRANIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY INTRACRANIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY INTRACRANIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY INTRACRANIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY FEMOROPOPLITEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY FEMOROPOPLITEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY FEMOROPOPLITEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY ILIAC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY ILIAC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY ILIAC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY RENAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY RENAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY RENAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 194. GCC PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 195. GCC PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 196. GCC PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. GCC PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 199. GCC PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 200. GCC PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. GCC PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. G7 PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 227. G7 PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 228. G7 PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 229. G7 PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. G7 PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 231. G7 PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 232. G7 PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 233. G7 PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. G7 PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. NATO PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 238. NATO PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 239. NATO PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 240. NATO PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. NATO PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 242. NATO PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 243. NATO PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 244. NATO PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. NATO PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL PTA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA PTA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA PTA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA PTA BALLOON CATHETER MARKET SIZE, BY CONVENTIONAL BALLOON, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA PTA BALLOON CATHETER MARKET SIZE, BY DRUG COATED BALLOON, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA PTA BALLOON CATHETER MARKET SIZE, BY BALLOON MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA PTA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA PTA BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA PTA BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA PTA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA PTA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA PTA BALLOON CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)